Atlas Trials

Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease

Clinical trial NCT00069316 · COMPLETED

Trial details

NCT number
NCT00069316
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
West Nile Virus
Start date
2003-09-22
Primary completion
2007-06-27
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.